Less Than Half of New Drug Approvals Add Therapeutic Value Over Existing Treatments: Study

Less than half of the new drug approvals are actually providing therapeutic value to patients, according to a recent study published in The BMJ. Despite the increasing number of drugs being approved in both the U.S. and Europe, it seems that many of them are not significantly improving patient outcomes. The study focused on 124 first indications that were approved by the FDA and European Medicin..

• format_list_bulleted Pharmacology/BS
• · 2023. 7. 10.
• textsms

Biden Administration Imposes Penalties on 43 Drugs Due to Price Hikes

The Biden administration has implemented inflation penalties on 43 Medicare Part B drugs to reduce costs for older Americans, following the imposition of fines on 27 drugs in March. The Inflation Reduction Act (IRA) requires pharmaceutical manufacturers to justify price increases exceeding the inflation rate, with financial penalties imposed if justifications are found insufficient. Under the IR..

• format_list_bulleted Pharmacology/BS
• · 2023. 6. 11.
• textsms

Biden Administration Imposes Penalties on 43 Drugs Due to Price Hikes

The Biden administration is set to impose inflation penalties on 43 Medicare Part B drugs in Q3 of 2023, following the imposition of fines on 27 drugs in March. The Inflation Reduction Act stipulates that pharmaceutical manufacturers must provide justifications for any price increases exceeding the inflation rate, with financial penalties imposed if deemed insufficient. The latest actions are ex..

• format_list_bulleted Pharmacology/BS
• · 2023. 6. 10.
• textsms